JP Morgan Cazenove Sticks With “Overweight” Rating for St James’s Place PLC (LON:STJ) stock. What’s the Best Move for Investors?


St James’s Place PLC (LON:STJ) Rating Reaffirmed

In a recent research report issued by JP Morgan Cazenove on Tuesday, 8 December, The Rating on St James’s Place PLC (LON:STJ) shares of a ‘”Overweight”‘ was reaffirmed.

From a total of 18 analysts covering St James’s Place PLC (LON:STJ) stock, 11 rate it a ”Buy”, 1 a “Sell”, and 7 a ”Hold”. This means that 58% of the ratings are positive. The highest target price is GBX 1197 while the lowest target price is GBX 785. The mean of all analyst targets is GBX 1023.5 with a 3.77% above today’s (GBX 998.47) stock price. St James’s Place PLC was the topic of 47 analyst reports since July 23, 2015 according to the firm StockzIntelligence Inc. Barclays Capital maintained shares on December 1 with “Overweight” rating. Deutsche Bank maintained shares with “Buy” rating and GBX 980 target share price in a report from an October 28. Goldman Sachs maintained STJ stock in a recent report from November 27 with “Buy” rating. Barclays Capital maintained the rating on October 28. Barclays Capital has a “Overweight” rating and a GBX 1100 price target on shares. Finally, Credit Suisse maintained the stock with “Neutral” rating in a report issued on a November 5.

The stock decreased 0.55% or GBX 5.53 on December 7, striking GBX 998.47. Approximately shares of stock traded hands. St. James’s Place plc (LON:STJ) has risen 6.75% since May 11, 2015 and is uptrending. It has outperformed by 7.83% the S&P500.

JP Morgan Cazenove Sticks With

The overall sentiment of institutions has increased to 1.36 in Q2 2015. Its up 0.53, from 0.83 in 2015Q2. The ratio increased, as 53 institutions have sold all the shares of St. James’s Place plc that they owned while 170 funds have taken shares off the table. 68 funds have purchased shares for the first time while 235 added to their positions. These institutions now hold 225.36 million shares or 4.37% less than the 235.67 million shares they owned in 2015Q2.

The Fund Perkins Capital Management Inc currently is holding shares equating to 6.69% of its total portfolio in St. James’s Place plc representing a total of 95,338 shares. Another fund,Conatus Capital Management Lp, is holding a total of 1.45 million shares equating to 5.79% of their holdings. Additionally, Endurant Capital Management Lp has a 245,526 share stake in St. James’s Place plc which represents 5.17% of their total portfolio. The Fund, Garland Capital Management Inc, based out of Washington, has also built up a stake in the stock, which represents a total of 4.21% of their total portfolio. Finally Sanders Capital Llc, a fund which is based in the state of New York reported a total holdings of 4.88 million shares.

Insider activity is a very important aspect to track on any stock. Going back to April 24, 2015, shareholders of St. James’s Place plc have witnessed 0 buys, and a total of 2 sales equating to a net activity of approximately $7.46 million . Murphy Mark W. sold 859 shares worth approximately $62,698. Starks Daniel J sold 100,000 shares worth approximately $7.39 million. Zellers Jason sold 396 shares worth approximately $28,924. Hill Barbara B sold 3,229 shares worth approximately $229,711. The company insider Fecho Jeff sold 5,174 shares worth $369,786.

St. James’s Place plc is a United Kingdom parent firm of the St. The company has a market cap of 5.19 billion GBP. James’s Place Wealth Management Group, which provides wealth management advice, investment management and related services to businesses and individuals across the United Kingdom. It has 29.72 P/E ratio. The Firm operates in four divisions: Life, Unit Trust, Distribution and Other.

According to Zacks Investment Research, “St. Jude Medical, Inc. is dedicated to making life better for cardiac, neurological and chronic pain patients worldwide through excellence in medical device technology and services. The Company has five major focus areas that include cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation.” Get a free copy of the Zacks research report on St. James’s Place plc (STJ).